JPM · NYQ · Financial Services
JPMorgan Chase & Co.
Also onShortfallConsensus DriftCrosscheck
Implied value per share
USD 324.94
Market price
USD 349.67
Implied upside
-7.1%
5-year forecast · Perpetuity growth terminal value · Mid-year discounting · Base case
Value Per Share
Same forecast, different terminal treatment. Percentages vs price.
Forecast Cashflows
Reporting currency (USD). Outflows negative.
| Line | FY26 | FY27 | FY28 | FY29 | FY30 | CAGR |
|---|---|---|---|---|---|---|
| Revenue | USD 204.6bn | USD 230.1bn | USD 258.9bn | USD 291.3bn | USD 327.7bn | +12.5% |
| EBIT | USD 81.9bn | USD 92.1bn | USD 103.6bn | USD 116.6bn | USD 131.2bn | +12.5% |
| NOPAT | USD 65.1bn | USD 73.3bn | USD 82.4bn | USD 92.7bn | USD 104.3bn | +12.5% |
| Add depreciation & amortisation | USD 10.2bn | USD 11.5bn | USD 12.9bn | USD 14.5bn | USD 16.3bn | +12.5% |
| Less capital expenditure | USD -10.2bn | USD -11.5bn | USD -12.9bn | USD -14.5bn | USD -16.3bn | +12.5% |
| Less increase in working capital | USD -22.7bn | USD -25.6bn | USD -28.8bn | USD -32.4bn | USD -36.4bn | +12.5% |
| Free cashflow to firm | USD 42.4bn | USD 47.7bn | USD 53.6bn | USD 60.3bn | USD 67.9bn | +12.5% |
| Discount factor | 0.9591 | 0.8822 | 0.8115 | 0.7465 | 0.6867 | - |
| Present value | USD 40.7bn | USD 42.1bn | USD 43.5bn | USD 45.1bn | USD 46.6bn | +3.5% |
| Present Value Of The Forecast | USD 217.9bn | |||||
Discount Rate
Source shown per component. All overridable above.
| Risk-free rate | 5.00% | US 10-year Treasury (^TNX) |
| Equity risk premium | 5.50% | Market assumption |
| Beta | 0.983 | Reported 0.975, pulled toward 1.0 (Blume) |
| Cost of equity | 10.41% | Risk-free + beta x equity risk premium |
| Cost of debt | 7.00% | Implied cost of debt of 20.5% is not a credible funding cost, so risk-free + 2bp is assumed instead. Interest expense and reported debt are measuring different things - common for banks, whose interest expense includes deposits that total debt excludes. |
| Market capitalisation | USD 929.5bn | 65.0% of capital |
| Total debt | USD 500.0bn | 35.0% of capital, book value as a proxy |
| Tax rate | 20.5% | Effective, capped at statutory |
| WACC | 8.71% | E/V x Re + D/V x Rd x (1 - t) |
Terminal Value
Perpetuity growth is intrinsic. The exit multiple defaults to the company's current EV/EBITDA, so it answers a different question - what the shares are worth if today's rating holds and EBITDA grows as forecast.
Perpetuity growth at 2.50%
79% of EV
- Forecast FCFF, final year
- USD 67.9bn
- Capex at depreciation, working capital in reinvestment
- USD 104.3bn
- Less reinvestment at g/ROIC (28.7% of NOPAT)
- USD -29.9bn
- Capitalised
- USD 74.4bn
- ROIC (WACC floor)
- 8.7%
- Terminal value, undiscounted
- USD 1227.0bn
- Terminal value, discounted
- USD 842.5bn
- Enterprise value
- USD 1060.5bn
- Less net debt
- USD 156.6bn
- Equity value
- USD 903.8bn
Exit at 13.3x EBITDA
86% of EV
- Terminal value, undiscounted
- USD 1967.4bn
- Terminal value, discounted
- USD 1351.0bn
- Enterprise value
- USD 1568.9bn
- Less net debt
- USD 156.6bn
- Equity value
- USD 1412.3bn
Spread between methods: 44%.
Sensitivity
Value per share (USD) by discount rate and long-run growth.
| Long-run growth | |||||
|---|---|---|---|---|---|
| Discount rate | 1.50% | 2.00% | 2.50% | 3.00% | 3.50% |
| 6.71% | 449.80 | 452.20 | 454.68 | 457.28 | 460.03 |
| 7.71% | 377.15 | 378.89 | 380.63 | 382.37 | 384.11 |
| 8.71% | 321.98 | 323.46 | 324.93 | 326.41 | 327.89 |
| 9.71% | 278.42 | 279.69 | 280.96 | 282.24 | 283.51 |
| 10.71% | 243.21 | 244.31 | 245.42 | 246.53 | 247.63 |
Outlined: this model. Green text: above today's price of 349.67. Shading: distance from this model's own value.
Priced In
What each input would have to be to justify the current price, one at a time.
| Input | Model | Implied | Gap |
|---|---|---|---|
| Revenue growth, every year | 12.5% | 14.4% | +1.9pp |
| EBIT margin | 40.0% | 42.4% | +2.3pp |
| Discount rate | 8.7% | 8.2% | -0.5pp |
Live formulas, not pasted numbers - edit a driver and the workbook reprices.
Yahoo Finance and RBA data. General information, not advice. Methodology.